Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Dec-23 8:04 PM View:  | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 08-Dec-23 | Grant | 40,596 | -- | -- | 470% 8.64K to 49.24K | |
| 12-Dec-23 8:07 PM View: | Kolean Chad J Chief Financial Officer | Cellectar Biosciences, Inc. (CLRB) | 08-Dec-23 | Grant | 42,554 | -- | -- | 177308% 24 to 42.58K | |
| 12-Dec-23 8:05 PM View: | Shustov Andrei Senior Vice President, Medical | Cellectar Biosciences, Inc. (CLRB) | 08-Dec-23 | Grant | 47,856 | -- | -- | 666% 7.18K to 55.04K | |
| 12-Dec-23 8:09 PM View: | Lea Darrell Shane Chief Commercial Officer | Cellectar Biosciences, Inc. (CLRB) | 08-Dec-23 | Grant | 39,599 | -- | -- | 100% 0 to 39.6K | |
| 12-Dec-23 8:04 PM View: | Longcor Jarrod Chief Operating Officer | Cellectar Biosciences, Inc. (CLRB) | 08-Dec-23 | Grant | 42,927 | -- | -- | 420% 10.21K to 53.14K | |
| 14-Sep-21 4:00 PM View: | Swirsky Douglas J Director | Cellectar Biosciences, Inc. (CLRB) | 14-Sep-21 | Market Purchase | 25,000 | $1.04 | $26,000.00 | 100% 0 to 25.0K | (2%) |
| 07-Sep-21 4:01 PM View: | Driscoll Frederick W Director | Cellectar Biosciences, Inc. (CLRB) | 03-Sep-21 | Market Purchase | 19,417 | $1.04 | $20,244.20 | 100% 0 to 19.42K | (1%) |
| 05-Mar-21 5:45 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 04-Mar-21 | Market Purchase | 5,100 | $1.70 | $8,658.78 | 6% 81.3K to 86.4K | 2% |
| 28-Dec-20 4:31 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 28-Dec-20 | Private Purchase | 37,037 | $1.35 | $49,999.90 | 84% 44.26K to 81.3K | |
| 28-Dec-20 4:31 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 28-Dec-20 | Private Purchase | 29,630 | $1.35 | $40,000.50 | 41% 72.52K to 102.15K | |
| 28-Dec-20 4:30 PM View: | Elefant Dov Chief Financial Officer | Cellectar Biosciences, Inc. (CLRB) | 28-Dec-20 | Private Purchase | 7,407 | $1.35 | $9,999.45 | 170% 4.35K to 11.76K | |
| 08-Jun-20 4:08 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 05-Jun-20 | Market Purchase | 65,218 | $1.14 | $74,674.60 | 893% 7.3K to 72.52K | 78% |
| 08-Jun-20 4:08 PM View: | Elefant Dov Chief Financial Officer | Cellectar Biosciences, Inc. (CLRB) | 05-Jun-20 | Market Purchase | 4,348 | $1.14 | $4,978.46 | 100% 0 to 4.35K | 78% |
| 08-Jun-20 4:07 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 05-Jun-20 | Market Purchase | 21,740 | $1.14 | $24,892.30 | 97% 22.52K to 44.26K | 78% |
| 08-Jun-20 4:12 PM View: | Hill Stephen A Director | Cellectar Biosciences, Inc. (CLRB) | 04-Jun-20 | Market Purchase | 18,000 | $1.08 | $19,438.20 | 100% 0 to 18.0K | 89% |
| 04-Feb-20 4:01 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 03-Feb-20 | Grant | 40,000 | $2.71 | $108,400.00 | 100% 0 to 40.0K | (25%) |
| 04-Feb-20 4:02 PM View: | Elefant Dov Chief Financial Officer | Cellectar Biosciences, Inc. (CLRB) | 03-Feb-20 | Grant | 10,000 | $2.71 | $27,100.00 | 100% 0 to 10.0K | (25%) |
| 04-Feb-20 4:01 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 03-Feb-20 | Grant | 100,000 | $2.71 | $271,000.00 | 100% 0 to 100.0K | (25%) |
| 01-Mar-19 4:20 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 28-Feb-19 | Market Purchase | 100 | $2.00 | $200.25 | 1% 7.2K to 7.3K | < 1% |
| 30-Nov-18 6:23 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 30-Nov-18 | Market Purchase | 1,000 | $2.28 | $2,282.00 | 5% 21.35K to 22.35K | (11%) |
| 30-Nov-18 6:19 PM View: | Hill Stephen A Director | Cellectar Biosciences, Inc. (CLRB) | 29-Nov-18 | Market Sale | 992 | $2.21 | $2,192.41 | (100%) 0.99K to 0 | 9% |
| 17-Aug-18 6:14 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 16-Aug-18 | Market Purchase | 500 | $2.71 | $1,355.00 | 7% 6.7K to 7.2K | (25%) |
| 14-Mar-18 4:01 PM View: | Longcor Jarrod Chief Business Officer | Cellectar Biosciences, Inc. (CLRB) | 13-Mar-18 | Market Sale (Planned) | 13,000 | $1.18 | $15,397.20 | (16%) 80.0K to 67.0K | 83% |
| 14-Mar-18 4:01 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 12-Mar-18 | Market Sale (Planned) | 34,000 | $1.20 | $40,704.80 | (14%) 247.55K to 213.55K | 84% |
| 16-Nov-17 4:04 PM View: | Neis John Director | Cellectar Biosciences, Inc. (CLRB) | 14-Nov-17 | Market Sale | 5,214 | $1.49 | $7,790.76 | (< 1%) 631.32K to 626.1K | 87% |
| 20-Apr-17 6:01 PM View: | Longcor Jarrod Sr. VP of Corp Dev & Ops | Cellectar Biosciences, Inc. (CLRB) | 18-Apr-17 | Grant | 80,000 | -- | -- | 100% 0 to 80.0K | |
| 20-Apr-17 6:02 PM View: | Kolean Chad J VP, Chief Financial Officer | Cellectar Biosciences, Inc. (CLRB) | 18-Apr-17 | Grant | 80,000 | -- | -- | 100% 0 to 80.0K | |
| 20-Apr-17 6:01 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 18-Apr-17 | Grant | 200,000 | -- | -- | 421% 47.55K to 247.55K | |
| 18-Apr-17 6:30 PM View: | Friend John E. II VP, Chief Medical Officer | Cellectar Biosciences, Inc. (CLRB) | 17-Apr-17 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 30-Nov-16 6:59 PM View: | Neis John Director | Cellectar Biosciences, Inc. (CLRB) | 29-Nov-16 | Market Purchase | 333,333 | $1.49 | $496,666.00 | 112% 297.98K to 631.32K | (88%) |
| 01-Nov-16 8:45 PM View: | Hertzberg Richard | Cellectar Biosciences, Inc. (CLRB) | 31-Oct-16 | Market Sale | 21,000 | $2.03 | $42,609.00 | (7%) 301.0K to 280.0K | 87% |
| 14-Jun-16 7:13 PM View: | Hertzberg Richard | Cellectar Biosciences, Inc. (CLRB) | 21-Apr-16 | Market Purchase | 3,758 | $1.90 | $7,140.20 | < 1% 594.48K to 598.24K | (87%) |
| 21-Apr-16 6:00 PM View: | Caruso James V President and CEO Director | Cellectar Biosciences, Inc. (CLRB) | 20-Apr-16 | Market Purchase | 46,948 | $2.12 | $99,529.80 | 7825% 0.6K to 47.55K | (88%) |
| 21-Apr-16 6:03 PM View: | Neis John Director | Cellectar Biosciences, Inc. (CLRB) | 20-Apr-16 | Market Purchase | 234,742 | $2.12 | $497,653.00 | 371% 63.24K to 297.98K | (88%) |
| 21-Apr-16 6:01 PM View: | Berns Paul L Director | Cellectar Biosciences, Inc. (CLRB) | 20-Apr-16 | Market Purchase | 117,371 | $2.12 | $248,826.00 | 100% 0 to 117.37K | (88%) |
| 21-Apr-16 6:04 PM View: | Hill Stephen A Director | Cellectar Biosciences, Inc. (CLRB) | 20-Apr-16 | Market Purchase | 9,390 | $2.12 | $19,906.80 | 1772% 0.53K to 9.92K | (88%) |
| 14-Jun-16 7:13 PM View: | Hertzberg Richard | Cellectar Biosciences, Inc. (CLRB) | 15-Apr-16 | Market Purchase | 234,742 | $2.12 | $497,653.00 | 65% 359.74K to 594.48K | (88%) |
| 04-Jan-16 4:29 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 31-Dec-15 | Market Sale | 35,253 | $0.70 | $24,518.50 | (50%) 70.51K to 35.25K | 96% |
| 04-Jan-16 4:29 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 30-Dec-15 | Market Sale | 64,747 | $0.69 | $44,500.60 | (48%) 135.25K to 70.51K | 96% |
| 30-Dec-15 3:41 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 29-Dec-15 | Market Sale | 82,847 | $0.69 | $57,404.70 | (45%) 182.85K to 100.0K | 96% |
| 14-Jun-16 5:49 PM View: | Hertzberg Richard 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 28-Dec-15 | Market Purchase | 75,000 | $0.72 | $54,000.00 | 750% 10.0K to 85.0K | (96%) |
| 29-Dec-15 4:28 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 28-Dec-15 | Market Sale | 150,975 | $0.69 | $104,218.00 | (23%) 667.64K to 516.67K | 96% |
| 29-Dec-15 4:28 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 24-Dec-15 | Market Sale | 216,991 | $0.76 | $164,826.00 | (25%) 884.63K to 667.64K | 97% |
| 14-Jun-16 5:49 PM View: | Hertzberg Richard 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 24-Dec-15 | Market Purchase | 50,000 | $0.79 | $39,500.00 | 500% 10.0K to 60.0K | (97%) |
| 14-Jun-16 5:49 PM View: | Hertzberg Richard 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 22-Dec-15 | Market Purchase | 5,000 | $0.91 | $4,550.00 | 50% 10.0K to 15.0K | (97%) |
| 23-Dec-15 3:45 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 22-Dec-15 | Market Sale | 7,938 | $0.90 | $7,180.71 | (1%) 558.75K to 550.81K | 97% |
| 22-Dec-15 4:05 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 21-Dec-15 | Market Sale | 20,621 | $0.92 | $19,018.70 | (2%) 1.16M to 1.14M | 97% |
| 22-Dec-15 4:05 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 18-Dec-15 | Market Sale | 7,000 | $0.90 | $6,291.60 | (< 1%) 1.17M to 1.16M | 97% |
| 18-Dec-15 4:40 PM View: | Awm Investment Company, Inc. 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 17-Dec-15 | Market Sale | 18,240 | $0.88 | $16,080.40 | (2%) 1.21M to 1.19M | 97% |
| 14-Jun-16 5:49 PM View: | Hertzberg Richard 10% Owner | Cellectar Biosciences, Inc. (CLRB) | 16-Dec-15 | Market Purchase | 19,592 | $0.91 | $17,828.70 | 196% 10.0K to 29.59K | (97%) |
